NYSE: ABBV
AbbVie Inc Earnings & Revenue

ABBV past earnings growth

How has ABBV's earnings growth performed historically?
Company
67.97%
Industry
10.68%
Market
82.89%
ABBV's earnings have grown faster (29.42% per year) than the US Drug Manufacturers - General industry average (8.89%)
Performance
ABBV's earnings have grown slower (29.42% per year) than the US market average (77.34%)
Performance
ABBV's earnings growth is accelerating - its growth over the last year (67.97%) is above its 5-year compound annual rate (29.42%)
Performance

ABBV past revenue growth

How has ABBV's revenue growth performed historically?
Company
11.04%
Industry
6.62%
Market
16.55%
ABBV's revenue has grown faster (11.54% per year) than the US Drug Manufacturers - General industry average (4.07%)
Performance
ABBV's revenue has grown slower (11.54% per year) than the US market average (15.67%)
Performance
ABBV's revenue growth is slowing down - its growth over the last year (11.04%) is below its 5-year compound annual rate (11.54%)
Performance

ABBV earnings and revenue history

Current Revenue
$36.2B
Current Earnings
$7.0B
Current Profit Margin
19.2%

ABBV Return on equity

Current Company
-305.6%
Current Industry
10.9%
Current Market
-36.3%
ABBV's Return on Equity (-305.6%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

ABBV Return on assets

Current Company
7.1%
Current Industry
8.5%
Current Market
6.2%
ABBV is generating lower Return on Assets (7.1%) than the US Drug Manufacturers - General industry average (8.27%)
Performance

ABBV Return on capital employed

Current Company
7.53%
Current Industry
12.8%
ABBV's ability to generate Return on Capital (7.53%) has decreased compared to 3 years ago (17.34%)
Performance

ABBV earnings dates

Next earnings date
Oct 30, 2020

AbbVie Earnings & Revenue FAQ

On May 01, 2020, AbbVie (NYSE: ABBV) reported Q1 2020 earnings per share (EPS) of $2.02, up 22.42% year over year. Total AbbVie earnings for the quarter were $3.01 billion. In the same quarter last year, AbbVie's earnings per share (EPS) was $1.65.
On May 01, 2020, AbbVie (NYSE: ABBV) reported Q1 2020 revenue of $8.62 billion up 10.1% year over year. In the same quarter last year, AbbVie's revenue was $7.83 billion.
As of Q4 2020, AbbVie's earnings has grown 67.97% year over year. This is 57.29 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 10.68%. AbbVie's earnings in the past year totalled $6.96 billion.
As of Q4 2020, AbbVie's revenue has grown 11.04% year over year. This is 4.43 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 6.62%. AbbVie's revenue in the past year totalled $36.23 billion.
AbbVie's earnings date is Oct 30, 2020. Add ABBV to your watchlist to be reminded of ABBV's next earnings announcement.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics